Navaneethan U,Venkatesh PG,Shen B .2010 .Clostridium difficile infection and inflammatory bowel disease: Understanding the evolving relationship. World J Gastroenterol, 16 : 4892-904.
Sears P,Crook DW,Louie TJ,Miller MA,Weiss K. .2012 .Fidaxomicin attains high fecal concentrations with minimal plasma concentrations following oral administration in patients with Clostridium difficile infection. Clin Infect Dis, 55(Suppl 2) : S116-20.
Nerandzic M,Mullane K,Miller M,Babakhani F,Donskey C .2012 .Reduced acquisition and over growth of vancomycin‑resistant enterococci and Candida species in patients treated with Fidaxomicin versus vancomycin for Clostridium difficile infection. Clin Infect Dis, 55 : S1216.
Louie TJ,Cannon K,Byrne B,Emery J,Ward L,Eyben M .2012 .Fidaxomicin preserves the intestinal microbiome during and after treatment of Clostridium difficile infection (CDI) and reduces both toxin reexpression and recurrence of CDI. Clin Infect Dis, 55(Suppl 2) : S132-42.
Daniels T,So TY .2011 .Fidaxomicin for the Treatment of Clostridium difficile infection in the pediatric population - Not quite so soon yet. Gastroenterol Res, 4 : 93-6.
Louie TJ,Miller MA,Mullane KM,Weiss K,Lentnek A,Golan Y .2011 .Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med, 364 : 4223-1.
Wilkins TD,Lyerly DM .2003 .Clostridium difficile testing: After 20 years, still challenging. J Clin Microbiol, 41 : 5314.
Gerding DN,Johnson S,Peterson LR,Mulligan ME,Silva J .1995 .Clostridium difficile‑associated diarrhea and colitis. Infect Control Hosp Epidemiol, 16 : 459-77.
Walley T,Milson D. .1990 .Loperamide related toxic megacolon in Clostridium difficile colitis. Postgrad Med J, 66 : 582.
Ananthakrishnan AN,Issa M,Binion DG .2010 .Clostridium difficile and inflammatory bowel disease. Med Clin North Am, 94 : 135-53.
Hashemi S,Nasrollah A,Rajabi M. .2013 .Irrational antibiotic prescribing: A local issue or global concern?. EXCLI J, 12 : 384-95.
Ambrose N. .1989 .The effects of single doses of antibiotics on fecal flora with a reference to their mode of excretion. J Drug Dev, : 233-41.
Bartlett JG. .2002 .Clinical practice. Antibiotic‑associated diarrhea. N Engl J Med, 346 : 334-9.
Bignardi GE .1998 .Risk factors for Clostridium difficile infection. J Hosp Infect, 40 : 1-15.
Gaynes R,Rimland D,Killum E,Lowery HK,Johnson TM,Killgore G .2004 .Outbreak of Clostridium difficile infection in a long‑term care facility: Association with gatifloxacin use. Clin Infect Dis, 38 : 640-5.
Loo VG,Poirier L,Miller MA,Oughton M,Libman MD,Michaud S .2005 .A predominantly clonal multii‑nstitutional outbreak of Clostridium difficile‑associated diarrhea with high morbidity and mortality. N Engl J Med, 353 : 2442-9.
Pépin J,Saheb N,Coulombe MA,Alary ME,Corriveau MP,Authier S .2005 .Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficilea‑ssociated diarrhea: A cohort study during an epidemic in Quebec. Clin Infect Dis, 41 : 1254-60.
.2006 .S u n e n s h i n e R H , M c D o n a l d L C . C l o s t r i d i u m difficile‑associated disease: New challenges from an established pathogen. Cleve Clin J Med, 73 : 187-97.